Immediate Impact
1 by Nobel laureates 43 standout
Citing Papers
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Patricia Steinert being referenced
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
2019
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patricia Steinert | 85 | 36 | 173 | 50 | 19 | 243 | |
| Hui Wang | 71 | 56 | 186 | 27 | 31 | 267 | |
| Lamis Eldjerou | 63 | 30 | 169 | 25 | 22 | 245 | |
| Vipul Sheth | 98 | 22 | 174 | 22 | 22 | 259 | |
| Kathleen Ruehle | 119 | 17 | 206 | 26 | 24 | 280 | |
| Núria Martínez‐Cibrián | 63 | 10 | 174 | 49 | 21 | 266 | |
| Yuehui Lin | 38 | 25 | 238 | 56 | 25 | 277 | |
| Marion Subklewe | 61 | 11 | 197 | 33 | 23 | 232 | |
| Robin Sanderson | 40 | 22 | 208 | 67 | 26 | 290 | |
| David M. Cordas dos Santos | 47 | 12 | 219 | 32 | 16 | 268 | |
| Alex H. Chang | 35 | 30 | 241 | 42 | 23 | 273 |
All Works
Login with ORCID to disown or claim papers
Loading papers...